CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease

Kenichi Takayasu, Yukio Muramatsu, Yasunori Mizuguchi, Takuji Okusaka, Kazuaki Shimada, Tadatoshi Takayama, Michiie Sakamoto

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

OBJECTIVE. The purpose of this study was to clarify the natural outcomes of hypoattenuating nodular lesions in patients with virus-related chronic liver disease depicted on dynamic CT. MATERIALS AND METHODS. Sixty lesions (mean size, 1.3 cm) exhibiting hypoattenuation or isoattenuation in the arterial and delayed phases of dynamic CT were retrospectively evaluated with additional CT (mean, six examinations) for a mean period of 838 days. The primary end point was emergence of hyperattenuating areas within hypoattenuating lesions, a phenomenon called attenuation conversion. Cumulative attenuation conversion rates suggesting rates of malignant transformation were calculated with the Kaplan-Meier method, and factors affecting attenuation conversion rate were analyzed with the Cox proportional hazard model. RESULTS. Thirty-six (60%) of 60 hypoattenuating lesions developed to hyperattenuating lesions, 21 were unchanged, and three disappeared spontaneously. The 36 lesions that became hyperattenuating were divided into two subgroups according to lesion enhancement pattern: hyper-in-hypoattenuating (n = 25) and entirely hyperattenuating (n = 11). The cumulative attenuation conversion rates for the 60 hypoattenuating lesions were 15.8%, 44.3%, and 58.7% at 1, 2, and 3 years. The hyper-in-hypoattenuating lesions showed more rapid progression to entirely enhanced lesions. Positive results for hepatitis C viral antibody (p = 0.028) and initial lesion size (p = 0.007) showed a positive correlation with attenuation conversion rate. CONCLUSION. Hypoattenuating hepatic nodular lesions in chronic liver disease depicted on dynamic CT have high malignant potential and should be followed with special attention to conversion from hypoattenuation to hyperattenuation to determine the optimal timing of treatment.

Original languageEnglish
Pages (from-to)454-463
Number of pages10
JournalAmerican Journal of Roentgenology
Volume187
Issue number2
DOIs
Publication statusPublished - 2006 Aug

Fingerprint

Liver Diseases
Chronic Disease
Viral Antibodies
Viruses
Hepatitis C Antibodies
Proportional Hazards Models
Liver

Keywords

  • Dynamic CT
  • Hepatocarcinogenesis
  • Liver disease
  • Oncologic imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. / Takayasu, Kenichi; Muramatsu, Yukio; Mizuguchi, Yasunori; Okusaka, Takuji; Shimada, Kazuaki; Takayama, Tadatoshi; Sakamoto, Michiie.

In: American Journal of Roentgenology, Vol. 187, No. 2, 08.2006, p. 454-463.

Research output: Contribution to journalArticle

Takayasu, Kenichi ; Muramatsu, Yukio ; Mizuguchi, Yasunori ; Okusaka, Takuji ; Shimada, Kazuaki ; Takayama, Tadatoshi ; Sakamoto, Michiie. / CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease. In: American Journal of Roentgenology. 2006 ; Vol. 187, No. 2. pp. 454-463.
@article{3d162d21ecb3496da7c7e770907ba4c0,
title = "CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease",
abstract = "OBJECTIVE. The purpose of this study was to clarify the natural outcomes of hypoattenuating nodular lesions in patients with virus-related chronic liver disease depicted on dynamic CT. MATERIALS AND METHODS. Sixty lesions (mean size, 1.3 cm) exhibiting hypoattenuation or isoattenuation in the arterial and delayed phases of dynamic CT were retrospectively evaluated with additional CT (mean, six examinations) for a mean period of 838 days. The primary end point was emergence of hyperattenuating areas within hypoattenuating lesions, a phenomenon called attenuation conversion. Cumulative attenuation conversion rates suggesting rates of malignant transformation were calculated with the Kaplan-Meier method, and factors affecting attenuation conversion rate were analyzed with the Cox proportional hazard model. RESULTS. Thirty-six (60{\%}) of 60 hypoattenuating lesions developed to hyperattenuating lesions, 21 were unchanged, and three disappeared spontaneously. The 36 lesions that became hyperattenuating were divided into two subgroups according to lesion enhancement pattern: hyper-in-hypoattenuating (n = 25) and entirely hyperattenuating (n = 11). The cumulative attenuation conversion rates for the 60 hypoattenuating lesions were 15.8{\%}, 44.3{\%}, and 58.7{\%} at 1, 2, and 3 years. The hyper-in-hypoattenuating lesions showed more rapid progression to entirely enhanced lesions. Positive results for hepatitis C viral antibody (p = 0.028) and initial lesion size (p = 0.007) showed a positive correlation with attenuation conversion rate. CONCLUSION. Hypoattenuating hepatic nodular lesions in chronic liver disease depicted on dynamic CT have high malignant potential and should be followed with special attention to conversion from hypoattenuation to hyperattenuation to determine the optimal timing of treatment.",
keywords = "Dynamic CT, Hepatocarcinogenesis, Liver disease, Oncologic imaging",
author = "Kenichi Takayasu and Yukio Muramatsu and Yasunori Mizuguchi and Takuji Okusaka and Kazuaki Shimada and Tadatoshi Takayama and Michiie Sakamoto",
year = "2006",
month = "8",
doi = "10.2214/AJR.05.0705",
language = "English",
volume = "187",
pages = "454--463",
journal = "American Journal of Roentgenology",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "2",

}

TY - JOUR

T1 - CT evaluation of the progression of hypoattenuating nodular lesions in virus-related chronic liver disease

AU - Takayasu, Kenichi

AU - Muramatsu, Yukio

AU - Mizuguchi, Yasunori

AU - Okusaka, Takuji

AU - Shimada, Kazuaki

AU - Takayama, Tadatoshi

AU - Sakamoto, Michiie

PY - 2006/8

Y1 - 2006/8

N2 - OBJECTIVE. The purpose of this study was to clarify the natural outcomes of hypoattenuating nodular lesions in patients with virus-related chronic liver disease depicted on dynamic CT. MATERIALS AND METHODS. Sixty lesions (mean size, 1.3 cm) exhibiting hypoattenuation or isoattenuation in the arterial and delayed phases of dynamic CT were retrospectively evaluated with additional CT (mean, six examinations) for a mean period of 838 days. The primary end point was emergence of hyperattenuating areas within hypoattenuating lesions, a phenomenon called attenuation conversion. Cumulative attenuation conversion rates suggesting rates of malignant transformation were calculated with the Kaplan-Meier method, and factors affecting attenuation conversion rate were analyzed with the Cox proportional hazard model. RESULTS. Thirty-six (60%) of 60 hypoattenuating lesions developed to hyperattenuating lesions, 21 were unchanged, and three disappeared spontaneously. The 36 lesions that became hyperattenuating were divided into two subgroups according to lesion enhancement pattern: hyper-in-hypoattenuating (n = 25) and entirely hyperattenuating (n = 11). The cumulative attenuation conversion rates for the 60 hypoattenuating lesions were 15.8%, 44.3%, and 58.7% at 1, 2, and 3 years. The hyper-in-hypoattenuating lesions showed more rapid progression to entirely enhanced lesions. Positive results for hepatitis C viral antibody (p = 0.028) and initial lesion size (p = 0.007) showed a positive correlation with attenuation conversion rate. CONCLUSION. Hypoattenuating hepatic nodular lesions in chronic liver disease depicted on dynamic CT have high malignant potential and should be followed with special attention to conversion from hypoattenuation to hyperattenuation to determine the optimal timing of treatment.

AB - OBJECTIVE. The purpose of this study was to clarify the natural outcomes of hypoattenuating nodular lesions in patients with virus-related chronic liver disease depicted on dynamic CT. MATERIALS AND METHODS. Sixty lesions (mean size, 1.3 cm) exhibiting hypoattenuation or isoattenuation in the arterial and delayed phases of dynamic CT were retrospectively evaluated with additional CT (mean, six examinations) for a mean period of 838 days. The primary end point was emergence of hyperattenuating areas within hypoattenuating lesions, a phenomenon called attenuation conversion. Cumulative attenuation conversion rates suggesting rates of malignant transformation were calculated with the Kaplan-Meier method, and factors affecting attenuation conversion rate were analyzed with the Cox proportional hazard model. RESULTS. Thirty-six (60%) of 60 hypoattenuating lesions developed to hyperattenuating lesions, 21 were unchanged, and three disappeared spontaneously. The 36 lesions that became hyperattenuating were divided into two subgroups according to lesion enhancement pattern: hyper-in-hypoattenuating (n = 25) and entirely hyperattenuating (n = 11). The cumulative attenuation conversion rates for the 60 hypoattenuating lesions were 15.8%, 44.3%, and 58.7% at 1, 2, and 3 years. The hyper-in-hypoattenuating lesions showed more rapid progression to entirely enhanced lesions. Positive results for hepatitis C viral antibody (p = 0.028) and initial lesion size (p = 0.007) showed a positive correlation with attenuation conversion rate. CONCLUSION. Hypoattenuating hepatic nodular lesions in chronic liver disease depicted on dynamic CT have high malignant potential and should be followed with special attention to conversion from hypoattenuation to hyperattenuation to determine the optimal timing of treatment.

KW - Dynamic CT

KW - Hepatocarcinogenesis

KW - Liver disease

KW - Oncologic imaging

UR - http://www.scopus.com/inward/record.url?scp=33746621639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746621639&partnerID=8YFLogxK

U2 - 10.2214/AJR.05.0705

DO - 10.2214/AJR.05.0705

M3 - Article

C2 - 16861551

AN - SCOPUS:33746621639

VL - 187

SP - 454

EP - 463

JO - American Journal of Roentgenology

JF - American Journal of Roentgenology

SN - 0361-803X

IS - 2

ER -